Saturday, 23 October 2021

 

 

LATEST NEWS Establishment of 400 Nagarvans in Country on anvil : Ashwini Kumar Choubey Lt Governor pays homage to brave soldiers, civilians martyred in the October 1947 terror attack by Pakistan army Chairperson FSSAI reviews functioning of J&K Drug & Food Control Department DC Shopian chairs meeting on implementation of Forest Rights Act DC Shopian reviews Winter preparedness in the district DDC Anantnag reviews pace/ progress of ongoing work projects by various departments DG Horticulture conducts extensive visit of Pulwama Union MoS for W&CD and AYUSH presides over one–day capacity building program for potential farmers at GUMC&H Ganderbal Chief Secretary approves implementation of "District Good Governance Index" in districts of J&K Dr Arun Kumar Mehta inaugurates Mining Department’s Web Portal Advisor Farooq Ahmad Khan attends closing ceremony of District Badminton Championship at GDC Pampore Awareness programme on World Iodine Deficiency Day held in Doda AYUSH Kishtwar celebrates ‘Magic Week’ under Azadi Ka Amrut Mahotsav Bulletin on COVID-19 : 108 fresh cases reported, 326195 recovered so far across J&K Doda Police organises debate competition on “Role of Police in Nation Building’ Samantha Ruth Prabhu could simply seek apology rather than filing defamation cases Deepika Padukone, Ranveer Singh likely to bid for new IPL team: Report I am hoping that 5-0 record in T20 World Cup will become 5-1 : Younis Khan 'Molnupiravir may be a game changer in fight against Covid-19' Facebook to pay French publishers for reusing their content 95% people do not need BJP : Akhilesh Yadav

 

WHO validates China's Sinopharm Covid vaccine for emergency use

Coronavirus, COVID 19, Novel Coronavirus, Covaxin, Covishield, Covid-19 Vaccine, COVID-19 Vaccination, COVID Vaccination, Coronavirus Vaccine, Oxygen, #OxygenCylinders, #oxygen, Oxygen Cylinders, SARS-CoV-2, World Health Organization, WHO, Sinopharm, Sinopharm vaccine, Beijing Bio-Institute of Biological Products Co Ltd

Web Admin

Web Admin

5 Dariya News

Geneva , 07 May 2021

The World Health Organization (WHO) on Friday approved the Covid-19 vaccine developed by China's Sinopharm for emergency use.The move paves the way for the Sinopharm vaccine to be rolled out globally."This afternoon, the WHO gave emergency use listing to Sinopharm, Beijing's Covid-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality," WHO Director-General Tedros Ghebreyesus said during a webinar on Covid-19.The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group."The Sinopharm product is an inactivated vaccine called SARS-CoV-2 Vaccine (Vero Cell). Its easy storage requirements make it highly suitable for low-resource settings," said the WHO.The Sinopharm vaccine is already in use in 42 countries around the world.Earlier this week, the European Medicine Agency (EMA) started a rolling review of the second Chinese Covid-19 vaccine called Sinovac, Xinhua news agency reported."The vaccine triggers the production of antibodies that target SARS-CoV-2, the virus that causes Covid-19, and may help protect against the disease," said the EMA.The WHO has given emergency use for vaccines made by Pfizer-BioNTech, Moderna, Johnson and Johnson and the AstraZeneca jab (being producing in India as Covishield and South Korea).

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Covaxin , Covishield , Covid-19 Vaccine , COVID-19 Vaccination , COVID Vaccination , Coronavirus Vaccine , Oxygen , #OxygenCylinders , #oxygen , Oxygen Cylinders , SARS-CoV-2 , World Health Organization , WHO , Sinopharm , Sinopharm vaccine , Beijing Bio-Institute of Biological Products Co Ltd

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD